Bifogade filer
ScandiDos Unveils Delta4 SRS Pro at ESTRO 2026: Setting a New Standard for Stereotactic QA
Kurs
+2,05%
Likviditet
0,00 MSEK
Prenumeration
Kalender
| Est. tid* | ||
| 2026-12-15 | 08:00 | Kvartalsrapport 2027-Q2 |
| 2026-10-21 | N/A | Årsstämma |
| 2026-09-17 | 08:00 | Kvartalsrapport 2027-Q1 |
| 2026-06-17 | 08:00 | Bokslutskommuniké 2026 |
| 2026-03-18 | - | Kvartalsrapport 2026-Q3 |
| 2025-12-16 | - | Kvartalsrapport 2026-Q2 |
| 2025-10-24 | - | X-dag ordinarie utdelning SDOS 0.00 SEK |
| 2025-10-23 | - | Årsstämma |
| 2025-09-18 | - | Kvartalsrapport 2026-Q1 |
| 2025-06-18 | - | Bokslutskommuniké 2025 |
| 2025-03-12 | - | Kvartalsrapport 2025-Q3 |
| 2024-12-17 | - | Kvartalsrapport 2025-Q2 |
| 2024-10-24 | - | X-dag ordinarie utdelning SDOS 0.00 SEK |
| 2024-10-23 | - | Årsstämma |
| 2024-09-18 | - | Kvartalsrapport 2025-Q1 |
| 2024-06-18 | - | Bokslutskommuniké 2024 |
| 2024-03-13 | - | Kvartalsrapport 2024-Q3 |
| 2023-12-12 | - | Kvartalsrapport 2024-Q2 |
| 2023-10-18 | - | X-dag ordinarie utdelning SDOS 0.00 SEK |
| 2023-10-17 | - | Årsstämma |
| 2023-09-13 | - | Kvartalsrapport 2024-Q1 |
| 2023-06-15 | - | Bokslutskommuniké 2023 |
| 2023-03-08 | - | Kvartalsrapport 2023-Q3 |
| 2022-12-07 | - | Kvartalsrapport 2023-Q2 |
| 2022-10-18 | - | X-dag ordinarie utdelning SDOS 0.00 SEK |
| 2022-10-17 | - | Årsstämma |
| 2022-09-13 | - | Kvartalsrapport 2023-Q1 |
| 2022-06-28 | - | Bokslutskommuniké 2022 |
| 2022-03-11 | - | Kvartalsrapport 2022-Q3 |
| 2021-12-14 | - | Kvartalsrapport 2022-Q2 |
| 2021-10-21 | - | X-dag ordinarie utdelning SDOS 0.00 SEK |
| 2021-10-20 | - | Årsstämma |
| 2021-09-23 | - | Kvartalsrapport 2022-Q1 |
| 2021-06-29 | - | Bokslutskommuniké 2021 |
| 2021-03-10 | - | Kvartalsrapport 2021-Q3 |
| 2020-12-16 | - | Kvartalsrapport 2021-Q2 |
| 2020-10-07 | - | X-dag ordinarie utdelning SDOS 0.00 SEK |
| 2020-10-06 | - | Årsstämma |
| 2020-09-25 | - | Kvartalsrapport 2021-Q1 |
| 2020-06-26 | - | Bokslutskommuniké 2020 |
| 2020-03-10 | - | Kvartalsrapport 2020-Q3 |
| 2019-12-18 | - | Kvartalsrapport 2020-Q2 |
| 2019-10-09 | - | X-dag ordinarie utdelning SDOS 0.00 SEK |
| 2019-10-08 | - | Årsstämma |
| 2019-09-12 | - | Kvartalsrapport 2020-Q1 |
| 2019-06-28 | - | Bokslutskommuniké 2019 |
| 2018-12-14 | - | Kvartalsrapport 2019-Q2 |
| 2018-10-03 | - | X-dag ordinarie utdelning SDOS 0.00 SEK |
| 2018-10-02 | - | Årsstämma |
| 2018-06-28 | - | Bokslutskommuniké 2018 |
| 2018-03-22 | - | Kvartalsrapport 2018-Q3 |
| 2017-12-15 | - | Kvartalsrapport 2018-Q2 |
| 2017-10-03 | - | X-dag ordinarie utdelning SDOS 0.00 SEK |
| 2017-10-02 | - | Årsstämma |
| 2017-09-29 | - | Kvartalsrapport 2018-Q1 |
| 2017-06-28 | - | Bokslutskommuniké 2017 |
| 2017-03-22 | - | Kvartalsrapport 2017-Q3 |
| 2016-12-15 | - | Kvartalsrapport 2017-Q2 |
| 2016-09-21 | - | X-dag ordinarie utdelning SDOS 0.00 SEK |
| 2016-09-20 | - | Årsstämma |
| 2016-09-20 | - | Kvartalsrapport 2017-Q1 |
| 2016-06-30 | - | Bokslutskommuniké 2016 |
| 2016-03-15 | - | Kvartalsrapport 2016-Q3 |
| 2015-12-11 | - | Kvartalsrapport 2016-Q2 |
| 2015-09-24 | - | X-dag ordinarie utdelning SDOS 0.00 SEK |
| 2015-09-23 | - | Årsstämma |
| 2015-09-23 | - | Kvartalsrapport 2016-Q1 |
| 2015-06-23 | - | Bokslutskommuniké 2015 |
| 2015-03-26 | - | Kvartalsrapport 2015-Q3 |
| 2014-12-19 | - | Kvartalsrapport 2015-Q2 |
| 2014-10-14 | - | Årsstämma |
| 2014-09-24 | - | X-dag ordinarie utdelning SDOS 0.00 SEK |
| 2014-09-23 | - | Kvartalsrapport 2015-Q1 |
| 2014-06-13 | - | Bokslutskommuniké 2014 |
Beskrivning
| Land | Sverige |
|---|---|
| Lista | First North Stockholm |
| Sektor | Hälsovård |
| Industri | Medicinteknik |
Intresserad av bolagets nyckeltal?
Analysera bolaget i Börsdata!
Vem äger bolaget?
All ägardata du vill ha finns i Holdings!
ScandiDos, a global leader in radiotherapy quality assurance, is proud to introduce Delta4 SRS Pro. This next-generation patient QA system enables high-precision 3D measurements at the isocenter for complex SRS and SBRT treatments.
At this year’s ESTRO congress in Stockholm, ScandiDos is showcasing its latest innovation, Delta4 SRS Pro. The system is purpose-built to meet the extreme demands of stereotactic radiotherapy (SRS and SBRT), where accuracy is paramount.
Precision Without Compromise
Stereotactic treatments are characterized by small target volumes, steep dose gradients, and non-coplanar beam geometries. These complexities require verification methods that can accurately mirror how the treatment is delivered to the patient. Currently, clinics are often forced to make compromises when performing quality assurance for stereotactic procedures, as existing systems fail to fully account for complex delivery angles and the extreme precision required.
Delta4 SRS Pro addresses these challenges by enabling true 3D measurement at the isocenter. The system utilizes an innovative detector geometry featuring three orthogonal planes and a total of 2916 isotropic diodes, specifically designed to minimize directional dependence and ensure unparalleled accuracy.
"With Delta4 SRS Pro, we aim to eliminate the compromises often associated with stereotactic QA," says Anders Murman, acting CEO of ScandiDos. "The system measures the 3D dose where it matters most—at the isocenter—reflecting the full treatment geometry, including non-coplanar deliveries, without any simplifications. The patented detector technology enables volumetric stereotactic QA with unprecedented precision."
Advancing the Delta4 Family
Delta4 SRS Pro expands the existing ScandiDos product portfolio by offering enhanced spatial resolution and full support for non-coplanar beam geometries, including 90° couch rotations.
Visit Us at ESTRO 2026
Attendees of ESTRO 2026 in Stockholm are invited to visit ScandiDos at Booth C05:04 to experience the system firsthand and discuss the future of quality assurance with our experts.
For more information, please visit the product website.
Delta4 SRS Pro is currently being showcased as a demonstration system and is not yet available for commercial sale.
CONTACT
Anders Murman, acting CEO, ScandiDos: investor@scandidos.com, +46 18-472 30 20
ScandiDos AB (publ), 556613-0927
Uppsala Science Park, 751 83 Uppsala
ABOUT SCANDIDOS
ScandiDos is an innovative forward-thinking company with groundbreaking software and hardware solutions for patient quality assurance in modern radiation therapy. Our Delta4 Family of products delivers a comprehensive QA solution, making the treatment process safe and efficient. We reinforce the confidence in radiotherapy clinics by providing professionals at the clinics with power and performance through independent QA.
The head office is in Uppsala Science Park, where product development is carried out. Sales are carried out by sales offices in the USA, Malaysia, and France, directly in the Nordic countries and through distributors in over 50 countries.
ScandiDos is listed on NASDAQ First North Stockholm with the ticker code SDOS. Certified Adviser is Tapper Partners AB. Additional investor information can be found at Scandidos.com. Product information can be found on Delta4family.com